Low-Grade Endotoxemia and Thrombosis in COVID-19
- PMID: 34092777
- PMCID: PMC8183715
- DOI: 10.14309/ctg.0000000000000348
Low-Grade Endotoxemia and Thrombosis in COVID-19
Abstract
Introduction: Patients with community-acquired pneumonia display enhanced levels of lipopolysaccharides (LPS) compared with controls, suggesting that low-grade endotoxemia may be implicated in vascular disturbances. It is unknown whether this occurs in patients with coronavirus 2019 (COVID-19) and its impact on thrombotic complications.
Methods: We measured serum levels of zonulin, a marker of gut permeability, LPS, and D-dimer in 81 patients with COVID-19 and 81 healthy subjects; the occurrence of thrombotic events in COVID-19 during the intrahospital stay was registered.
Results: Serum LPS and zonulin were higher in patients with COVID-19 than in control subjects and, in COVID-19, significantly correlated (R = 0.513; P < 0.001). Among the 81 patients with COVID-19, 11 (14%) experienced thrombotic events in the arterial (n = 5) and venous circulation (n = 6) during a median follow-up of 18 days (interquartile range 11-27 days). A logistic regression analysis showed that LPS (P = 0.024) and D-dimer (P = 0.041) independently predicted thrombotic events.
Discussion: The study reports that low-grade endotoxemia is detectable in patients with COVID-19 and is associated with thrombotic events. The coexistence of low-grade endotoxemia with enhanced levels of zonulin may suggest enhanced gut permeability as an underlying mechanism.
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.
Conflict of interest statement
Figures
Comment in
-
Reply to Chen and Vitetta.Clin Transl Gastroenterol. 2022 Jan 13;13(1):e00448. doi: 10.14309/ctg.0000000000000448. Clin Transl Gastroenterol. 2022. PMID: 35029168 Free PMC article. No abstract available.
-
Gut Dysbiosis Could Be a Major Factor for the Effects of Low-Grade Endotoxemia in COVID-19 Comment on: Low-Grade Endotoxemia and Thrombosis in COVID-19.Clin Transl Gastroenterol. 2022 Jan 12;13(1):e00440. doi: 10.14309/ctg.0000000000000440. Clin Transl Gastroenterol. 2022. PMID: 35080510 Free PMC article. No abstract available.
References
-
- Cangemi R, Della Valle P, Calvieri C, et al. . Low-grade endotoxemia and clotting activation in the early phase of pneumonia. Respirology 2016;21:1465–71. - PubMed
-
- Cangemi R, Casciaro M, Rossi E, et al. . Platelet activation is associated with myocardial infarction in patients with pneumonia. J Am Coll Cardiol 2014;64:1917–25. - PubMed
-
- Carnevale R, Sciarretta S, Valenti V, et al. . Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: Implication for myocardial infarction. Eur Heart J 2020;41:3156–65. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
